Recommendations for the Clinical Evaluation of Agents for Treatment of Osteoporosis: Consensus of an Expert Panel Representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the-Reference-Cited by-同舟云学术

Recommendations for the Clinical Evaluation of Agents for Treatment of Osteoporosis: Consensus of an Expert Panel Representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the

Published:2007-09-10 Issue:1 Volume:23 Page:159-165
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Silverman Stuart L,Cummings Steven R,Watts Nelson B

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference3 articles.

1. Draft guidance for industry on the preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis: Request for comments;Food and Drug Administration;Fed Regist,2004

2. Physician ratings of appropriate indications for three procedures: Theoretical indications vs indications used in practice;Park;Am J Public Health,1999

3. European Medicines Agency 2005 Guideline on the Evaluation of New Medicinal Products in the Treatment of Osteoporosis www.emea.eu.int/pdfs/human/ewp/055295en.pdf

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical challenges raised by osteoporosis-related clinical trials;Journal of Medical Ethics and History of Medicine;2023-12-08

2. The antifracture efficacy of vitamin D in adults — are we assessing it reliably? A systematic review;Endokrynologia Polska;2023-10-30

3. Measuring Drug Therapy Effect on Osteoporotic Fracture Risk by Trabecular Bone Lacunarity: The LOTO Study;Biomedicines;2023-03-04

4. Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines;Maturitas;2022-09

5. Postmenopausal osteoporosis: risk evaluation and treatment options;Minerva Obstetrics and Gynecology;2021-12